Enzo Biochem, Inc. (ENZ)

Enzo Biochem Income Statement

Financials in millions USD. Fiscal year is August - July.

Year	2023	2022	2021	2020	2019
Revenue	31.06	32.64	117.73	76.02	81.17
Revenue Growth (YoY)	-4.85%	-72.27%	54.87%	-6.34%	-19.64%
Cost of Revenue	19.5	19.21	64.15	52.25	57.92
Gross Profit	11.57	13.43	53.58	23.77	23.25
Selling, General & Admin	32.4	28.52	49.63	49.69	47.27
Research & Development	3.9	2.44	3.25	4.45	3.18
Other Operating Expenses	0	-0.5	0	0	-28.93
Operating Expenses	36.3	30.46	52.89	54.14	21.52
Operating Income	-24.74	-17.03	0.69	-30.37	1.73
Interest Expense / Income	1.12	-0.18	-0.01	-0.45	-1.06
Other Expense / Income	-46.15	1.41	-7.18	-1.39	0.3
Pretax Income	20.29	-18.26	7.88	-28.52	2.49
Net Income	20.29	-18.26	7.88	-28.52	2.49
Shares Outstanding (Basic)	49	49	48	48	47
Shares Outstanding (Diluted)	49	49	48	48	47
Shares Change	1.16%	0.56%	1.32%	0.46%	1.07%
EPS (Basic)	0.41	-0.38	0.16	-0.60	0.05
EPS (Diluted)	0.41	-0.38	0.16	-0.60	0.05
Free Cash Flow	-39.74	-20.06	-4.05	-19.35	-3.32
Free Cash Flow Per Share	-0.81	-0.41	-0.08	-0.41	-0.07
Gross Margin	37.24%	41.14%	45.51%	31.27%	28.64%
Operating Margin	-79.64%	-52.16%	0.59%	-39.95%	2.14%
Profit Margin	65.32%	-55.94%	6.69%	-37.52%	3.07%
Free Cash Flow Margin	-127.93%	-61.46%	-3.44%	-25.45%	-4.09%
EBITDA	24.09	-15.61	10.52	-26.19	4.47
EBITDA Margin	77.56%	-47.83%	8.94%	-34.46%	5.51%
Depreciation & Amortization	2.68	2.83	2.65	2.78	3.04
EBIT	21.41	-18.44	7.87	-28.97	1.43
EBIT Margin	68.93%	-56.49%	6.68%	-38.11%	1.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).